Platelet membrane glycoproteins: A historical review

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 5, 2014, Pages 577-584

  Nurden, Alan T ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

Bernard Soulier syndrome; Glanzmann thrombasthenia; inherited disorder; membrane glycoproteins; platelet

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN; POLYACRYLAMIDE GEL;

BERNARD SOULIER DISEASE; BLOOD VESSEL WALL; CROSSED IMMUNOELECTROPHORESIS; FIBRINOLYSIS; GLANZMANN DISEASE; GLYCOCALYX; HISTORY OF MEDICINE; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; TWO DIMENSIONAL GEL ELECTROPHORESIS; CHEMISTRY; HISTORY; PHYSIOLOGY; THROMBOCYTE; ULTRASTRUCTURE;

BERNARD-SOULIER SYNDROME; BLOOD PLATELETS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; THROMBASTHENIA;

EID: 84905252442     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1383826     Document Type: Review

References (64)

1. Nurden A. T., Phillips D. R., George J. N. Platelet membrane glycoproteins: historical perspectives. J Thromb Haemost: 2006; 4 1 3 9
2. Nurden A. T. Platelet membrane glycoproteins: a look back into the past and a view to the future. Thromb Haemost: 2007; 98 1 49 54 (Pubitemid 47074177)
3. French J. E. Blood platelets: morphological studies on their properties and life cycle. Br J Haematol: 1967; 13 4 595 602
4. Sheppard B. L., French J. E. Platelet adhesion in rabbit arteries observed by scanning and transmission electron microscopy. Nature: 1970; 225 5237 1054 1055
5. Behnke O. Electron microscopical observations on the surface coating of human blood platelets. J Ultrastruct Res: 1968; 24 1 51 69
6. Skaer R. J., Emmines J. P., Skaer H. B. The fine structure of cell contacts in platelet aggregation. J Ultrastruct Res: 1979; 69 1 28 42 (Pubitemid 10196444)
7. Marcus A. J., Ullman H. L., Safier L. B. Studies on human platelet gangliosides. J Clin Invest: 1972; 51 10 2602 2612
8. Pepper D. S., Jamieson G. A. Studies on glycoproteins. 3. Isolation of sialylglycopeptides from human platelet membranes. Biochemistry: 1969; 8 8 3362 3369
9. Pepper D. S., Jamieson G. A. Isolation of a macroglycopeptide from human platelets. Biochemistry: 1970; 9 19 3706 3713
10. Nurden A. T. Platelet macroglycopeptide. Nature: 1974; 251 5471 151 153
11. MacPherson G. G. Synthesis and localization of sulphated mucopolysaccharide in megakaryocytes and platelets of the rat, an analysis by electron-microscope autoradiography. J Cell Sci: 1972; 10 3 705 717
12. Ward J. V., Radojewski-Hutt A. M., Packham M. A., Haslam R. J., Mustard J. F. Loss of sulfated proteoglycan from the surface of rabbit platelets during adenosine 5′-diphosphate-induced aggregation. Lab Invest: 1976; 35 4 337 342
13. Nachman R. L., Ferris B. Studies on the proteins of human platelet membranes. J Biol Chem: 1972; 247 14 4468 4475
14. Phillips D. R. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry: 1972; 11 24 4582 4588
15. Nachman R. L., Hubbard A., Ferris B. Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem: 1973; 248 8 2928 2936
16. George J. N., Potterf R. D., Lewis P. C., Sears D. A. Studies on platelet plasma membranes. I. Characterization of surface proteins of human platelets labeled with diazotized (125i)-diiodosulfanilic acid. J Lab Clin Med: 1976; 88 2 232 246
17. McGregor J. L., Clemetson K. J., James E., et al. Glycoproteins of platelet membranes from Glanzmann's thrombasthenia. A comparison with normal using carbohydrate-specific or protein-specific labelling techniques and high-resolution two-dimensional gel electrophoresis. Eur J Biochem: 1981; 116 2 379 388 (Pubitemid 11039074)
18. Phillips D. R., Agin P. P. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest: 1977; 60 3 535 545 (Pubitemid 8180857)
19. Hagen I., Bjerrum O. J., Solum N. O. Characterization of human platelet proteins solubilized with Triton X-100 and examined by crossed immunoelectrophoresis. Reference patterns of extracts from whole platelets and isolated membranes. Eur J Biochem: 1979; 99 1 9 22 (Pubitemid 9246920)
20. Hagen I., Nurden A., Bjerrum O. J., Solum N. O., Caen J. Immunochemical evidence for protein abnormalities in platelets from patients with Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Clin Invest: 1980; 65 3 722 731 (Pubitemid 10179735)
21. Kunicki T. J., Nurden A. T., Pidard D., Russell N. R., Caen J. P. Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossed-immunoelectrophoresis. Blood: 1981; 58 6 1190 1197 (Pubitemid 12251147)
22. Kunicki T. J., Pidard D., Rosa J. P., Nurden A. T. The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood: 1981; 58 2 268 278 (Pubitemid 11047343)
23. Nurden A. T., Dupuis D., Pidard D., Kieffer N., Kunicki T. J., Cartron J. P. Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome. J Clin Invest: 1982; 70 6 1281 1291 (Pubitemid 13168009)
24. Caen J. P., Castaldi P. A., Leclerc J. C., et al. Congenital bleeding disorders with long bleeding time and normal platelet count. I. Glanzmann's thrombasthenia. Am J Med: 1966; 41 1 4 26
25. Born G. VR, Cross M. J. Effects of inorganic ions and of plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol: 1964; 170 397 414
26. Mustard J. F., Packham M. A., Kinlough-Rathbone R. L., Perry D. W., Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood: 1978; 52 2 453 466
27. Nurden A. T., Caen J. P. An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol: 1974; 28 2 253 260
28. Nurden A. T., Caen J. P. Specific roles for platelet surface glycoproteins in platelet function. Nature: 1975; 255 5511 720 722
29. Phillips D. R., Jenkins C. S., Lüscher E. F., Larrieu M. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature: 1975; 257 5527 599 600
30. Shulman S., Karpatkin S. Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Biol Chem: 1980; 255 9 4320 4327 (Pubitemid 10051111)
31. Castaldi P. A., Caen J. Platelet fibrinogen. J Clin Pathol: 1965; 18 5 579 585
32. Bernard J., Soulier J. P. Sur une nouvelle variété de dystrophie thrombocytairehémoŗragipare congénitale. Sem Hop: 1948; 24 Spec. No. 3217 3223
33. Gröttum K. A., Solum N. O. Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haematol: 1969; 16 3 277 290
34. Bithell T. C., Parekh S. J., Strong R. R. Platelet-function studies in the Bernard-Soulier syndrome. Ann N Y Acad Sci: 1972; 201 145 160
35. Weiss H. J., Tschopp T. B., Baumgartner H. R., Sussman I. I., Johnson M. M., Egan J. J. Decreased adhesion of giant (Bernard-Soulier) platelets to subendothelium. Further implications on the role of the von Willebrand factor in hemostasis. Am J Med: 1974; 57 6 920 925
36. Jenkins C. S., Phillips D. R., Clemetson K. J., Meyer D., Larrieu M. J., Lüscher E. F. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest: 1976; 57 1 112 124
37. Nurden A. T., Dupuis D., Kunicki T. J., Caen J. P. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest: 1981; 67 5 1431 1440 (Pubitemid 11099358)
38. Clemetson K. J., McGregor J. L., James E., Dechavanne M., Lüscher E. F. Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis. J Clin Invest: 1982; 70 2 304 311 (Pubitemid 12042629)
39. Cartron J. P., Nurden A. T. Galactosyltransferase and membrane glycoprotein abnormality in human platelets from Tn-syndrome donors. Nature: 1979; 282 5739 621 623 (Pubitemid 10213921)
40. Marguerie G. A., Plow E. F., Edgington T. S. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem: 1979; 254 12 5357 5363 (Pubitemid 9231900)
41. Bennett J. S., Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest: 1979; 64 5 1393 1401
42. Ginsberg M. H., Painter R. G., Forsyth J., Birdwell C., Plow E. F. Thrombin increases expression of fibronectin antigen on the platelet surface. Proc Natl Acad Sci U S A: 1980; 77 2 1049 1053 (Pubitemid 10105054)
43. Plow E. F., Srouji A. H., Meyer D., Marguerie G., Ginsberg M. H. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem: 1984; 259 9 5388 5391 (Pubitemid 14144984)
44. Coller B. S., Peerschke E. I., Scudder L. E., Sullivan C. A. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest: 1983; 72 1 325 338 (Pubitemid 13025874)
45. Pidard D., Montgomery R. R., Bennett J. S., Kunicki T. J. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem: 1983; 258 20 12582 12586 (Pubitemid 14231175)
46. Gartner T. K., Williams D. C., Minion F. C., Phillips D. R. Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin. Science: 1978; 200 4347 1281 1283 (Pubitemid 8405756)
47. Phillips D. R., Jennings L. K., Edwards H. H. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol: 1980; 86 1 77 86 (Pubitemid 10027729)
48. Hoyer L. W. Von Willebrand's disease. Prog Hemost Thromb: 1976; 3 231 287
49. Ruggeri Z. M., Zimmerman T. S. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest: 1980; 65 6 1318 1325 (Pubitemid 10122373)
50. Gralnick H. R., Williams S. B., Morisato D. K. Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets. Blood: 1981; 58 2 387 397 (Pubitemid 11047359)
51. Ruggeri Z. M., De Marco L., Gatti L., Bader R., Montgomery R. R. Platelets have more than one binding site for von Willebrand factor. J Clin Invest: 1983; 72 1 1 12 (Pubitemid 13026623)
52. Baumgartner H. R., Tschopp T. B., Meyer D. Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol: 1980; 44 1 127 139 (Pubitemid 10201715)
53. Coller B. S., Peerschke E. I., Scudder L. E., Sullivan C. A. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood: 1983; 61 1 99 110 (Pubitemid 13169772)
54. Ruan C., Tobelem G., McMichael A. J., et al. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol: 1981; 49 4 511 519 (Pubitemid 12193757)
55. George J. N., Nurden A. T., Phillips D. R. Molecular defects in interactions of platelets with the vessel wall. N Engl J Med: 1984; 311 17 1084 1098 (Pubitemid 14012519)
56. Coller B. S., Shattil S. J. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood: 2008; 112 8 3011 3025
57. Bledzka K., Smyth S. S., Plow E. F. Integrin αIIbβ3: from discovery to efficacious therapeutic target. Circ Res: 2013; 112 8 1189 1200
58. Vanhoorelbeke K., Ulrichts H., Van de Walle G., Fontayne A., Deckmyn H. Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des: 2007; 13 26 2684 2697 (Pubitemid 47430434)
59. Hollopeter G., Jantzen H. M., Vincent D., et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature: 2001; 409 6817 202 207 (Pubitemid 32144286)
60. Michelson A. D. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov: 2010; 9 2 154 169
61. Nieswandt B., Pleines I., Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost: 2011; 9 01 92 104
62. Brass L. F., Wannemacher K. M., Ma P., Stalker T. J. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost: 2011; 9 01 66 75
63. Jackson S. P. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med: 2011; 17 11 1423 1436
64. Deppermann C., Cherpokova D., Nurden P., et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest: 2013